Cargando…

Selective androgen receptor modulators in preclinical and clinical development

Androgen receptor (AR) plays a critical role in the function of several organs including primary and accessory sexual organs, skeletal muscle, and bone, making it a desirable therapeutic target. Selective androgen receptor modulators (SARMs) bind to the AR and demonstrate osteo- and myo-anabolic act...

Descripción completa

Detalles Bibliográficos
Autores principales:	Narayanan, Ramesh, Mohler, Michael L., Bohl, Casey E., Miller, Duane D., Dalton, James T.
Formato:	Texto
Lenguaje:	English
Publicado:	The Nuclear Receptor Signaling Atlas 2008
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2602589/ https://www.ncbi.nlm.nih.gov/pubmed/19079612 http://dx.doi.org/10.1621/nrs.06010

Ejemplares similares

Selective Androgen Receptor Modulators (SARMs) Negatively Regulate Triple-Negative Breast Cancer Growth and Epithelial:Mesenchymal Stem Cell Signaling
por: Narayanan, Ramesh, et al.
Publicado: (2014)

An Overview of Next-Generation Androgen Receptor-Targeted Therapeutics in Development for the Treatment of Prostate Cancer
por: Mohler, Michael L., et al.
Publicado: (2021)

Androgen Receptor: A Complex Therapeutic Target for Breast Cancer
por: Narayanan, Ramesh, et al.
Publicado: (2016)

Destroying the androgen receptor (AR)-potential strategy to treat advanced prostate cancer
por: Narayanan, Ramesh, et al.
Publicado: (2017)

MicroRNAs Are Mediators of Androgen Action in Prostate and Muscle
por: Narayanan, Ramesh, et al.
Publicado: (2010)

Selective androgen receptor modulators for the treatment of late onset male hypogonadism
por: Coss, Christopher C, et al.
Publicado: (2014)

The selective androgen receptor modulator GTx-024 (enobosarm) improves lean body mass and physical function in healthy elderly men and postmenopausal women: results of a double-blind, placebo-controlled phase II trial
por: Dalton, James T., et al.
Publicado: (2011)

Selective androgen receptor modulators: the future of androgen therapy?
por: Christiansen, Andrew R., et al.
Publicado: (2020)

Discovery and Preclinical Characterization of Novel Small Molecule TRK and ROS1 Tyrosine Kinase Inhibitors for the Treatment of Cancer and Inflammation
por: Narayanan, Ramesh, et al.
Publicado: (2013)

Androgen Receptor in Breast Cancer—Clinical and Preclinical Research Insights
por: Anestis, Aristomenis, et al.
Publicado: (2020)

Inhibiting androgen receptor splice variants with cysteine-selective irreversible covalent inhibitors to treat prostate cancer
por: Thiyagarajan, Thirumagal, et al.
Publicado: (2022)

Selective Androgen Receptor Modulator Induced Hepatotoxicity
por: Khan, Sohaib, et al.
Publicado: (2022)

Therapeutic targeting of the androgen receptor (AR) and AR variants in prostate cancer
por: Narayanan, Ramesh
Publicado: (2020)

Study Design and Rationale for the Phase 3 Clinical Development Program of Enobosarm, a Selective Androgen Receptor Modulator, for the Prevention and Treatment of Muscle Wasting in Cancer Patients (POWER Trials)
por: Crawford, Jeffrey, et al.
Publicado: (2016)

Selective Androgen Receptor Modulators: An Emerging Liver Toxin
por: Mohideen, Haseeb, et al.
Publicado: (2023)

Regulators of Androgen Action Resource: a one-stop shop for the comprehensive study of androgen receptor action
por: DePriest, Adam D., et al.
Publicado: (2016)

Androgen Receptor and Cardiovascular Disease: A Potential Risk for the Abuse of Supplements Containing Selective Androgen Receptor Modulators
por: Hall, Ellis, et al.
Publicado: (2023)

Drug‐Induced Liver Injury by Selective Androgenic Receptor Modulators
por: Flores, Joan Ericka, et al.
Publicado: (2020)

Combination of selective androgen and estrogen receptor modulators in orchiectomized rats
por: Roch, P. J., et al.
Publicado: (2022)

Role of the androgen receptor in breast cancer and preclinical analysis of enzalutamide
por: Cochrane, Dawn R, et al.
Publicado: (2014)

Preclinical Development of Seriniquinones as Selective Dermcidin Modulators for the Treatment of Melanoma
por: Hirata, Amanda S., et al.
Publicado: (2022)

Modulation of neointimal lesion formation by endogenous androgens is independent of vascular androgen receptor
por: Wu, Junxi, et al.
Publicado: (2014)

Dominant-Negative Androgen Receptor Inhibition of Intracrine Androgen-Dependent Growth of Castration-Recurrent Prostate Cancer
por: Titus, Mark A., et al.
Publicado: (2012)

Antiandrogens Act as Selective Androgen Receptor Modulators at the Proteome Level in Prostate Cancer Cells
por: Brooke, Greg N., et al.
Publicado: (2015)

Breakthrough in cachexia treatment through a novel selective androgen receptor modulator?!
por: Thum, Thomas, et al.
Publicado: (2011)

Selective androgen receptor modulators (SARMs) have specific impacts on the mouse uterus
por: Simitsidellis, Ioannis, et al.
Publicado: (2019)

Novel Covalent Modifier-Induced Local Conformational Changes within the Intrinsically Disordered Region of the Androgen Receptor
por: Harnish, Michael T., et al.
Publicado: (2023)

Drug-Induced Liver Injury Secondary to Enobosarm: A Selective Androgen Receptor Modulator
por: Weinblatt, Daniel, et al.
Publicado: (2022)

Comparison of in vitro approaches for predicting the metabolism of the selective androgen receptor modulator RAD140
por: Wagener, Felicitas, et al.
Publicado: (2023)

Preclinical evaluation of PSMA expression in response to androgen receptor blockade for theranostics in prostate cancer
por: Lückerath, Katharina, et al.
Publicado: (2018)

Identification of neuron selective androgen receptor inhibitors
por: Otto-Duessel, Maya, et al.
Publicado: (2017)

Simulating androgen receptor selection in designer yeast
por: Zhang, Haoran, et al.
Publicado: (2022)

FT-6876, a Potent and Selective Inhibitor of CBP/p300, is Active in Preclinical Models of Androgen Receptor-Positive Breast Cancer
por: Caligiuri, Maureen, et al.
Publicado: (2023)

Androgen receptor-mediated upregulation of quaking affects androgen receptor-related prostate cancer development and anti-androgen receptor therapy
por: Zhang, Keke, et al.
Publicado: (2018)

Role of nonhuman primate models in the discovery and clinical development of selective progesterone receptor modulators (SPRMs)
por: Chwalisz, Kristof, et al.
Publicado: (2006)

Identification and Synthesis of Selected In Vitro Generated Metabolites of the Novel Selective Androgen Receptor Modulator (SARM) 2f
por: Möller, Tristan, et al.
Publicado: (2023)

Roles for the Backdoor Pathway of Androgen Metabolism in Prostate Cancer Response to Castration and Drug Treatment
por: Fiandalo, Michael V., et al.
Publicado: (2014)

Ski-interacting protein (SKIP) interacts with androgen receptor in the nucleus and modulates androgen-dependent transcription
por: Abankwa, Daniel, et al.
Publicado: (2013)

Biological and Clinical Significance of Androgens and Androgen Receptor in Prostate Cancer
por: Koochekpour, Shahriar
Publicado: (2014)

SUMOylation modulates the transcriptional activity of androgen receptor in a target gene and pathway selective manner
por: Sutinen, Päivi, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_na0le1ibc25j3ofk26i9gq71st